HIV and noncommunicable disease comorbidities in the era of antiretroviral therapy: A vital agenda for research in low-and middle-income country settings

Journal of Acquired Immune Deficiency Syndromes

Volumn 67, Issue SUPPL.1, 2014, Pages

  Venkat Narayan, K M ^a   Miotti, Paolo G ^b   Anand, Nalini P ^c   Kline, Lydia Mann ^c   Harmston, Christine ^c   Gulakowski, Roman ^b   Vermund, Sten H ^d  

^a EMORY UNIVERSITY   (United States)

^b Office of Research Services   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

AIDS; antiretroviral therapy; comorbidities; developing country; disease complications; HIV; low and middle income countries; noncommunicable diseases; sub Saharan Africa

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ARTICLE; BONE DISEASE; CARDIOVASCULAR DISEASE; GASTROINTESTINAL DISEASE; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY DISEASE; LIVER DISEASE; LOWEST INCOME GROUP; LUNG DISEASE; MENTAL DISEASE; METABOLIC DISORDER; MIDDLE INCOME GROUP; NEOPLASM; NEUROLOGIC DISEASE; NON COMMUNICABLE DISEASE; NUTRITIONAL DISORDER; PRIORITY JOURNAL; SOCIAL STATUS; SUBSTANCE ABUSE; UROGENITAL TRACT DISEASE;

AFRICA SOUTH OF THE SAHARA; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ASIA; CARIBBEAN REGION; COMORBIDITY; DEVELOPING COUNTRIES; HIV INFECTIONS; HUMANS; LATIN AMERICA;

EID: 84906060948     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000267     Document Type: Article

References (91)

1. Walensky RP, Paltiel AD, Losina E, et al. The survival benefits of AIDS treatment in the United States. J Infect Dis. 2006;194:11-19.
2. April MD, Wood R, Berkowitz BK, et al. The survival benefits of anti-retroviral therapy in South Africa. J Infect Dis. 2014;209:491-499.
3. Uyei J, Coetzee D, Macinko J, et al. Integrated delivery of HIV and tuberculosis services in sub-Saharan Africa: a systematic review. Lancet Infect Dis. 2011;11:855-867.
4. Sarnquist CC, Rahangdale L, Maldonado Y. Reproductive health and family planning needs among HIV-infected women in Sub-Saharan Africa. Curr HIV Res. 2013;11:160-168.
5. Boyd MA, Cooper DA. Optimisation of HIV care and service delivery: doing more with less. Lancet. 2012;380:1860-1866.
6. Madzimbamuto FD, Ray S, Mogobe KD. Integration of HIV care into maternal health services: a crucial change required in improving quality of obstetric care in countries with high HIV prevalence. BMC Int Health Hum Rights. 2013;13:27.
7. Kim JY, Farmer P, Porter ME. Redefining global health-care delivery. Lancet. 2013;382:1060-1069.
8. Munderi P, Grosskurth H, Droti B, et al. What are the essential components of HIV treatment and care services in low and middle-income countries: an overview by settings and levels of the health system? AIDS. 2012;26(suppl 2):S97-S103.
9. Ross DA, South A, Weller I, et al. HIV treatment and care systems: the way forward. AIDS. 2012;26(suppl 2):S147-S152.
10. Kenny J, Mulenga V, Hoskins S, et al. The needs for HIV treatment and care of children, adolescents, pregnant women and older people in low-income and middle-income countries. AIDS. 2012;26(suppl 2):S105-S116.
11. Samb B, Desai N, Nishtar S, et al. Prevention and management of chronic disease: a litmus test for health-systems strengthening in low-income and middle-income countries. Lancet. 2010;376:1785-1797.
12. World Health Organization. WHO Consolidated Guidelines on the Use of ARV Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. Geneva, Switzerland: WHO; 2013. Available at: http://apps.who.int/iris/bitstream/10665/85321/1/9789241505727- eng.pdf. Accessed May 20, 2014.
13. Magee MJ, Narayan KM. Global confluence of infectious and non-communicable diseases-the case of type 2 diabetes. Prev Med. 2013; 57:149-151.
14. Chu C, Selwyn PA. An epidemic in evolution: the need for new models of HIV care in the chronic disease era. J Urban Health. 2011;88: 556-566.
15. Bygbjerg IC. Double burden of noncommunicable and infectious diseases in developing countries. Science. 2012;337:1499-1501.
16. Geneau R, Hallen G. Toward a systemic research agenda for addressing the joint epidemics of HIV/AIDS and noncommunicable diseases. AIDS. 2012;26(suppl 1):S7-S10.
17. Bliss M. The Discovery of Insulin. Chicago, IL: University of Chicago Press; 2007:112-121.
18. Adebamowo CA, Casper C, Bhatia K, et al. Challenges in the detection, prevention, and treatment of HIV-associated malignancies in low-and middle-income countries in Africa. J Acquir Immune Defic Syndr. 2014; 67(suppl 1):S17-S26.
19. Kalyesubula R, Wearne N, Semitala FC, et al. HIV-associated renal and genitourinary comorbidities in Africa. J Acquir Immune Defic Syndr. 2014;67(suppl 1):S68-S78.
20. Ali MK, Magee MJ, Dave JA, et al. HIV and metabolic, body, and bone disorders: what we know from low-and middle-income countries. J Acquir Immune Defic Syndr. 2014;67(suppl 1):S27-S39.
21. Bloomfield GS, Khazanie P, Morris A, et al. HIV and noncommunicable cardiovascular and pulmonary diseases in low-and middle-income countries in the ART era: what we know and best directions for future research. J Acquir Immune Defic Syndr. 2014;67(suppl 1):S40-S53.
22. Chibanda D, Benjamin L, Weiss HA, Abas M. Mental, neurological, and substance use disorders in people living with HIV/AIDS in low-and middle-income countries. J Acquir Immune Defic Syndr. 2014;67(suppl 1):S54-S67.
23. Kelly P, Saloojee H, Chen JY, Chung RT. Noncommunicable diseases in HIV infection in low-and middle-income countries: gastrointestinal, hepatic, and nutritional aspects. J Acquir Immune Defic Syndr. 2014;67 (suppl 1):S79-S86.
24. Petersen M, Yiannoutsos CT, Justice A, Egger M. Observational research on NCDs in HIV-positive populations: conceptual and methodological considerations. J Acquir Immune Defic Syndr. 2014;67(suppl 1):S8-S16.
25. Hyle EP, Naidoo K, Su AE, et al. HIV, tuberculosis, and non-communicable diseases: what is known about the costs, effects, and cost-effectiveness of integrated care? J Acquir Immune Defic Syndr. 2014;67(suppl 1):S87-S95.
26. Crabtree-Ramirez B, Del Rio C, Grinsztejn B, Sierra-Madero J. HIV and noncommunicable diseases (NCDs) in Latin America: a call for an integrated and comprehensive response. J Acquir Immune Defic Syndr. 2014; 67(suppl 1):S96-S98.
27. Ananworavich J, Avihingsanon A. HIV and noncommunicable Diseases: the Asian perspective. J Acquir Immune Defic Syndr. 2014;67(suppl 1): S99-S103.
28. Vermund SH, Narayan KMV, Glass RI. Non-communicable diseases in HIV Survivors. Sci Transl Med. 2014;6(241):24.
29. Beyrer C, Sullivan PS, Sanchez J, et al. A call to action for comprehensive HIV services for men who have sex with men. Lancet. 2012;380: 424-438.
30. Bachireddy C, Soule MC, Izenberg JM, et al. Integration of health services improves multiple healthcare outcomes among HIV-infected people who inject drugs in Ukraine. Drug Alcohol Depend. 2014;134:106-114.
31. Greenfield SF, Shields A, Connery HS, et al. Integrated management of physician-delivered alcohol care for tuberculosis patients: design and implementation. Alcohol Clin Exp Res. 2010;34:317-330.
32. Jenkins R, Othieno C, Okeyo S, et al. Health system challenges to integration of mental health delivery in primary care in Kenya-perspectives of primary care health workers. BMC Health Serv Res. 2013;13:368.
33. Mall S, Sorsdahl K, Swartz L, et al. "I understand just a little." Perspectives of HIV/AIDS service providers in South Africa of providing mental health care for people living with HIV/AIDS. AIDS Care. 2012; 24:319-323.
34. Rachlis B, Sodhi S, Burciul B, et al. A taxonomy for community-based care programs focused on HIV/AIDS prevention, treatment, and care in resource-poor settings. Glob Health Action. 2013;6:1-21.
35. Lindegren ML, Kennedy CE, Bain-Brickley D, et al. Integration of HIV/AIDS services with maternal, neonatal and child health, nutrition, and family planning services. Cochrane Database Syst Rev. 2012;9: CD010119.
36. Parry CD, Petersen P, Carney T, et al. Opportunities for enhancing and integrating HIV and drug services for drug using vulnerable populations in South Africa. Int J Drug Policy. 2010;21:289-295.
37. Sylla L, Bruce RD, Kamarulzaman A, et al. Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services. Int J Drug Policy. 2007;18:306-312.
38. Remais JV, Zeng G, Li G, et al. Convergence of non-communicable and infectious diseases in low-and middle-income countries. Int J Epidemiol. 2013;42:221-227.
39. Chu C, Selwyn PA. Complications of HIV infection: a systems-based approach. Am Fam Physician. 2011;83:395-406.
40. Narh-Bana SA, Chirwa TF, Mwanyangala MA, et al. Adult deaths and the future: a cause-specific analysis of adult deaths from a longitudinal study in rural Tanzania 2003-2007. Trop Med Int Health. 2012;17: 1396-1404.
41. Chihana M, Floyd S, Molesworth A, et al. Adult mortality and probable cause of death in rural northern Malawi in the era of HIV treatment. Trop Med Int Health. 2012;17:e74-e83.
42. Chamie G, Kwarisiima D, Clark TD, et al; SEARCH Collaboration. Leveraging rapid community-based HIV testing campaigns for non-communicable diseases in rural Uganda. PLoS One. 2012;7:e43400.
43. Nishtar S, Bile KM, Ahmed A, et al. Integrated population-based surveillance of noncommunicable diseases: the Pakistan model. Am J Prev Med. 2005;29(5 suppl 1):102-106.
44. Modjarrad K, Vermund SH. Effect of treating co-infections on HIV-1 viral load: a systematic review. Lancet Infect Dis. 2010;10:455-463.
45. Liao L, Xing H, Su B, et al. Impact of HIV drug resistance on virologic and immunologic failure and mortality in a cohort of patients on antire-troviral therapy in China. AIDS. 2013;27:1815-1824.
46. Vermund SH, Powderly WG; Infectious Diseases Society of America; HIV Medicine Association of IDSA. Developing a human immunodeficiency virus/acquired immunodeficiency syndrome therapeutic research agenda for resource-limited countries: a consensus statement. Clin Infect Dis. 2003;37(suppl 1):S4-S12.
47. Zulu I, Schuman P, Musonda R, et al. Priorities for antiretroviral therapy research in sub-Saharan Africa: a 2002 consensus conference in Zambia. J Acquir Immune Defic Syndr. 2004;36:831-834.
48. Hirschhorn LR, Kaaya SF, Garrity PS, et al. Cancer and the "other" noncommunicable chronic diseases in older people living with HIV/AIDS in resource-limited settings: a challenge to success. AIDS. 2012;26(suppl 1):S65-S75.
49. Mwanahamuntu MH, Sahasrabuddhe VV, Kapambwe S, et al. Advancing cervical cancer prevention initiatives in resource-constrained settings: insights from the Cervical Cancer Prevention Program in Zambia. PLoS Med. 2011;8:e1001032.
50. Gatanaga H, Hayashida T, Tanuma J, et al. Prophylactic effect of antiretroviral therapy on hepatitis B virus infection. Clin Infect Dis. 2013;56: 1812-1819.
51. Bates M, O'Grady J, Mwaba P, et al. Evaluation of the burden of unsuspected pulmonary tuberculosis and co-morbidity with non-communicable diseases in sputum producing adult inpatients. PLoS One. 2012;7:e40774.
52. Creswell J, Raviglione M, Ottmani S, et al. Tuberculosis and noncommunicable diseases: neglected links and missed opportunities. Eur Respir J. 2011;37:1269-1282.
53. Madon T, Hofman KJ, Kupfer L, et al. Public health. Implementation science. Science. 2007;318:1728-1729.
54. Anand NP, Hofman KJ, Glass RI. The globalization of health research: harnessing the scientific diaspora. Acad Med. 2009;84:525-534.
55. Ciampa PJ, Vaz LM, Blevins M, et al. The association among literacy, numeracy, HIV knowledge and health-seeking behavior: a population-based survey of women in rural Mozambique. PLoS One 2012;7: e39391.
56. Rabkin M, Melaku Z, Bruce K, et al. Strengthening health systems for chronic care: leveraging HIV programs to support diabetes services in Ethiopia and Swaziland. J Trop Med. 2012;2012:137460.
57. Mounier-Jack S, Rudge JW, Phetsouvanh R, et al. Critical interactions between Global Fund-supported programmes and health systems: a case study in Lao People's Democratic Republic. Health Policy Plan. 2010;25 (suppl 1):i37-i42.
58. Hanvoravongchai P, Warakamin B, Coker R. Critical interactions between Global Fund-supported programmes and health systems: a case study in Thailand. Health Policy Plan. 2010;25(suppl 1):i53-i57.
59. Lawn SD, Harries AD, Wood R. Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings. Curr Opin HIV AIDS. 2010;5:18-26.
60. Ekouevi DK, Stringer E, Coetzee D, et al. Health facility characteristics and their relationship to coverage of PMTCT of HIV services across four African countries: the PEARL study. PLoS One. 2012;7:e29823.
61. Coleman R, Gill G, Wilkinson D. Noncommunicable disease management in resource-poor settings: a primary care model from rural South Africa. Bull World Health Organ. 1998;76:633-640.
62. Rudge JW, Phuanakoonon S, Nema KH, et al. Critical interactions between Global Fund-supported programmes and health systems: a case study in Papua New Guinea. Health Policy Plan. 2010;25(suppl 1): i48-i52.
63. Atun R, Pothapregada SK, Kwansah J, et al. Critical interactions between the Global Fund-supported HIV programs and the health system in Ghana. J Acquir Immune Defic Syndr. 2011;57(suppl 2):S72-S76.
64. Johnson K, Kennedy SB, Harris AO, et al. Strengthening the HIV/AIDS service delivery system in Liberia: an international research capacity-building strategy. J Eval Clin Pract. 2005;11:257-273.
65. Palen J, El-Sadr W, Phoya A, et al. PEPFAR, health system strengthening, and promoting sustainability and country ownership. J Acquir Immune Defic Syndr. 2012;60(suppl 3):S113-S119.
66. Eholié SP, Aoussi FE, Ouattara IS, et al. HIV treatment and care in resource-constrained environments: challenges for the next decade. J Int AIDS Soc. 2012;15:17334.
67. Ali MK, Rabadán-Diehl C, Flanigan J, et al. Systems and capacity to address noncommunicable diseases in low-and middle-income countries. Sci Transl Med. 2013;5:181cm4.
68. Oti SO. HIV and noncommunicable diseases: a case for health system building. Curr Opin HIV AIDS. 2013;8:65-69.
69. Gounder CR, Chaisson RE. A diagonal approach to building primary healthcare systems in resource-limited settings: women-centred integration of HIV/AIDS, tuberculosis, malaria, MCH and NCD initiatives. Trop Med Int Health. 2012;17:1426-1431.
70. Zewdie D, Cahn P, McClure C, et al. The role of HIV research in building health system capacity in developing countries. Curr Opin HIV AIDS. 2008;3:481-488.
71. Vermund SH, Sidat M, Weil LF, et al. Transitioning HIV care and treatment programs in southern Africa to full local management. AIDS. 2012;26:1303-1310.
72. Rabkin M, Kruk ME, El-Sadr WM. HIV, aging and continuity care: strengthening health systems to support services for noncommunicable diseases in low-income countries. AIDS. 2012;26(suppl 1):S77-S83.
73. Hogerzeil HV, Liberman J, Wirtz VJ, et al. Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration. Lancet. 2013;381:680-689.
74. Amuyunzu-Nyamongo M. Need for a multi-factorial, multi-sectorial and multi-disciplinary approach to NCD prevention and control in Africa. Glob Health Promot. 2010;17(2 suppl l):31-32.
75. Stuckler D, Basu S, McKee M. Drivers of inequality in Millennium Development Goal progress: a statistical analysis. PLoS Med. 2010;7:e1000241.
76. Maher D, Harries AD, Zachariah R, et al. A global framework for action to improve the primary care response to chronic non-communicable diseases: a solution to a neglected problem. BMC Public Health. 2009;9:355.
77. Odutayo A, Hirji N. Noncommunicable diseases in developing countries: focus on research capacity building. JAMA Intern Med. 2013;173:1031.
78. Rabkin M, Nishtar S. Scaling up chronic care systems: leveraging HIV programs to support noncommunicable disease services. J Acquir Immune Defic Syndr. 2011;57(suppl 2):S87-S90.
79. Boutayeb A. The double burden of communicable and non-communicable diseases in developing countries. Trans R Soc Trop Med Hyg. 2006;100:191-199.
80. Atun R, Bataringaya J. Building a durable response to HIV/AIDS: implications for health systems. J Acquir Immune Defic Syndr. 2011;57 (suppl 2):S91-S95.
81. Buvé A, Kalibala S, McIntyre J. Stronger health systems for more effective HIV/AIDS prevention and care. Int J Health Plann Manage. 2003;18 (suppl 1):S41-S51.
82. Shigayeva A, Atun R, McKee M, et al. Health systems, communicable diseases and integration. Health Policy Plan. 2010;25(suppl 1):i4-i20.
83. Ekouevi DK, Karcher S, Coffie PA. Strengthening health systems through HIV monitoring and evaluation in Sub-Saharan Africa. Curr Opin HIV AIDS. 2011;6:245-250.
84. Beaglehole R, Epping-Jordan J, Patel V, et al. Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health care. Lancet. 2008;372:940-949.
85. Bassett IV, Walensky RP. Integrating HIV screening into routine health care in resource-limited settings. Clin Infect Dis. 2010;50(suppl 3):S77-S84.
86. Coker R, Balen J, Mounier-Jack S, et al. A conceptual and analytical approach to comparative analysis of country case studies: HIV and TB control programmes and health systems integration. Health Policy Plan. 2010;25(suppl 1):i21-i31.
87. Kruk ME. HIV and health systems: research to bridge the divide. J Acquir Immune Defic Syndr. 2011;57(suppl 2):S120-S123.
88. El-Sadr WM, Abrams EJ. Scale-up of HIV care and treatment: can it transform healthcare services in resource-limited settings? AIDS. 2007;21 (suppl 5):S65-S70.
89. Grépin KA. Leveraging HIV programs to deliver an integrated package of health services: some words of caution. J Acquir Immune Defic Syndr. 2011;57(suppl 2):S77-S79.
90. Sliwa K, Damasceno A, Mayosi BM. Noncommunicable diseases in developing countries: focus on research capacity building-reply. JAMA Intern Med. 2013;173:1031-1032.
91. Tankwanchi ABS, Özden C, Vermund SH. Physician emigration from sub-Saharan Africa to the United States: analysis of the 2011 AMA physician masterfile. PLoS Med. 2013;10.